Home Cart Sign in  
Chemical Structure| 42017-89-0 Chemical Structure| 42017-89-0

Structure of Fenofibric acid
CAS No.: 42017-89-0

Chemical Structure| 42017-89-0

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

Fenofibric acid is an agonist of PPAR that can regulate lipid level. It also exhibits inhibition of COX-2.

Synonyms: FNF acid; NSC 281318; Procetofenic acid

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

DE Stock

US Stock

Asia Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Product Citations

Ingraham, Charles H. IV ; Stalinska, Joanna ; Carson, Sean C. ; Colley, Susan B. ; Rak, Monika ; Lassak, Adam , et al.

Abstract: Glioblastomas are highly aggressive brain tumors for which therapeutic options are very limited. In a quest for new anti-glioblastoma drugs, we focused on specific structural modifications to the benzoyl-phenoxy-acetamide (BPA) structure present in a common lipid-lowering drug, fenofibrate, and in our first prototype glioblastoma drug, PP1. Here, we propose extensive computational analyses to improve the selection of the most effective glioblastoma drug candidates. Initially, over 100 structural BPA variations were analyzed and their physicochemical properties, such as water solubility (- logS), calculated partition coefficient (ClogP), probability for BBB crossing (BBB_SCORE), probability for CNS penetration (CNS-MPO) and calculated cardiotoxicity (hERG), were evaluated. This integrated approach allowed us to select pyridine variants of BPA that show improved BBB penetration, water solubility, and low cardiotoxicity. Herein the top 24 compounds were synthesized and analyzed in cell culture. Six of them demonstrated glioblastoma toxicity with IC50 ranging from 0.59 to 3.24 µM. Importantly, one of the compounds, HR68, accumulated in the brain tumor tissue at 3.7 ± 0.5 µM, which exceeds its glioblastoma IC50 (1.17 µM) by over threefold.

Purchased from AmBeed: ; ; ; ; ; ; ; ; ; 2706-56-1 ; ; ; ; ; ; ; ; 20173-24-4 ; ; ; ; ; ; ; ; 42017-89-0 ; 90-45-9

Alternative Products

Product Details of Fenofibric acid

CAS No. :42017-89-0
Formula : C17H15ClO4
M.W : 318.75
SMILES Code : CC(C)(OC1=CC=C(C(C2=CC=C(Cl)C=C2)=O)C=C1)C(O)=O
Synonyms :
FNF acid; NSC 281318; Procetofenic acid
MDL No. :MFCD00792461
InChI Key :MQOBSOSZFYZQOK-UHFFFAOYSA-N
Pubchem ID :64929

Safety of Fenofibric acid

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H302-H315-H319-H335
Precautionary Statements:P261-P305+P351+P338

Isoform Comparison

Biological Activity

Target
  • PPARα

In Vitro:

Cell Line
Concentration Treated Time Description References
COS-7 cells 61.0 µM 10 hours To evaluate the effect of fenofibric acid on PPARγ-LBD-mediated gene transcription activation, results showed that fenofibric acid activated PPARγ-LBD-mediated transactivation with an EC50 of 61.0 µM. Int J Mol Sci. 2022 Apr 25;23(9):4726.
MCF-7 breast cancer cells 20 µM 24 hours To evaluate the effect of fenofibric acid on the antitumor effect of paclitaxel, results showed that fenofibric acid did not reduce the antitumor effect of paclitaxel Brain Behav Immun. 2021 Mar;93:172-185.
A549 non-small cell lung cancer cells 20 µM 24 hours To evaluate the effect of fenofibric acid on the antitumor effect of paclitaxel, results showed that fenofibric acid did not reduce the antitumor effect of paclitaxel Brain Behav Immun. 2021 Mar;93:172-185.
AML12 cells 104.7 µM (IC50) 24 hours To evaluate the toxicity of Mito-FFa on normal cells, results showed Mito-FFa had low toxicity on AML12 cells. Adv Sci (Weinh). 2023 Jul;10(20):e2300286.
MDA-MB-231 tumor cells 8 µM 24 hours To evaluate the cytotoxicity of Mito-FFa, results showed Mito-FFa had significant cytotoxicity on MDA-MB-231 cells. Adv Sci (Weinh). 2023 Jul;10(20):e2300286.
R28 retinal precursor cells 25 µM 24 hours To evaluate the antioxidant effect of Feno-FA on hypoxia-induced ROS generation, results showed that Feno-FA reduced ROS levels. Invest Ophthalmol Vis Sci. 2014 May 13;55(7):4568-76.
ARPE-19 cells 100 µM 3 days To investigate the effect of FA on high glucose and IL-1β-induced fibronectin and collagen IV overexpression. Results showed FA significantly reduced FN and Coll IV expression. Invest Ophthalmol Vis Sci. 2011 Aug 11;52(9):6348-54.
CAOV3 ovarian cancer cells 40 µM 48 hours To evaluate the effect of fenofibric acid on paclitaxel-induced cytotoxicity, results showed that fenofibric acid did not interfere with paclitaxel-induced cell death in CAOV3 cells. Cancers (Basel). 2020 Dec 29;13(1):69.
SKOV-3 ovarian cancer cells 40 µM 48 hours To evaluate the effect of fenofibric acid on paclitaxel-induced cytotoxicity, results showed that fenofibric acid did not interfere with paclitaxel-induced cell death in SKOV-3 cells. Cancers (Basel). 2020 Dec 29;13(1):69.
4T1 tumor cells 8 µM 6 hours To evaluate the effect of Mito-FFa on mitochondrial function, results showed Mito-FFa significantly increased mtROS generation and caused mitochondrial depolarization. Adv Sci (Weinh). 2023 Jul;10(20):e2300286.
GL261-Red-FLuc 5, 10, 25, 50 µM 96 hours To evaluate the cytotoxic effects of PP1 on GL261-Red-FLuc cells. Results showed that PP1 triggered extensive cell death after 96 hours. Transl Oncol. 2019 Jul;12(7):895-907.
U-87MG 5, 10, 25, 50 µM 96 hours To evaluate the cytotoxic effects of PP1 on U-87MG cells. Results showed that PP1 triggered extensive cell death after 96 hours. Transl Oncol. 2019 Jul;12(7):895-907.

In Vivo:

Species
Animal Model
Administration Dosage Frequency Description References
C57BL/6J mice High-fat diet-induced retinal pigment epithelium injury model Dietary administration 0.1% Once daily for 1 month Fenofibrate partially reversed the HFD-induced decrease in ERG c-wave amplitudes and suppressed oxidative injury and inflammatory response in RPE tissues Drug Des Devel Ther. 2023 Nov 21;17:3439-3452.
C57BL/6J mice Paclitaxel-induced peripheral neuropathy model Dietary administration 0.2% and 0.4% Continued for 4 weeks (before, during and after paclitaxel treatment) To evaluate the preventive effect of fenofibrate diet on paclitaxel-induced peripheral neuropathy, results showed that fenofibrate diet partially prevented mechanical hypersensitivity, completely prevented cold hypersensitivity, and restored the decrease in sensory nerve action potential amplitude and intra-epidermal nerve fiber density. Cancers (Basel). 2020 Dec 29;13(1):69.
Transgenic mice Human apo A-I transgenic mice Mixed in Mice chow for oral administration 0.5% (wt/wt) Once daily for 7 days To investigate the effect of fenofibrate on plasma apo A-I levels and hepatic apo A-I mRNA levels in human apo A-I transgenic mice. Results showed that treatment with 0.5% fenofibrate for 7 days increased plasma human apo A-I levels by 760% and hepatic human apo A-I mRNA levels by 97%. J Clin Invest. 1996 Jun 1;97(11):2408-16
C57BL/6J mice Oxygen-induced retinopathy (OIR) model Intraperitoneal injection 10 mg/kg Once daily from P12 to P16 To evaluate the protective effect of Feno-FA on retinal apoptosis and oxidative stress in the OIR model, results showed that Feno-FA reduced retinal apoptosis and oxidative stress. Invest Ophthalmol Vis Sci. 2014 May 13;55(7):4568-76.
C57BL/6J mice Oxygen-induced retinopathy (OIR) model Intraperitoneal injection 10 mg/kg Once daily from P12 to P17 To investigate the effect of PPARα agonist FA on retinal neovascularization and EPC mobilization in the OIR model. Results showed that FA significantly suppressed OIR-induced retinal neovascularization and EPC mobilization. Invest Ophthalmol Vis Sci. 2014 May 20;55(6):3820-32
C57BL/6J mice Paclitaxel-induced peripheral neuropathy model Intraperitoneal injection 150 mg/kg Once daily for 7 days To evaluate the preventive and reversal effects of fenofibrate and choline fenofibrate on paclitaxel-induced peripheral neuropathy, results showed that both drugs partially or completely reversed mechanical and cold hypersensitivity and reduced neuroinflammation through PPAR-α activation Brain Behav Immun. 2021 Mar;93:172-185.
BALB/c mice 4T1 breast tumor model Intratumoral injection 20, 60, 200 μg/Mice Single injection To evaluate the antitumor effect of Mito-FFa in vivo, results showed Mito-FFa significantly inhibited tumor growth and induced CD8+ T cell-dependent immune responses. Adv Sci (Weinh). 2023 Jul;10(20):e2300286.
Brown Norway rats Laser-induced choroidal neovascularization (CNV) model Intraperitoneal injection 25 mg/kg Once daily for 2 weeks Evaluate the effects of Feno-FA on laser-induced CNV, results showed Feno-FA significantly reduced vascular leakage and CNV volume Invest Ophthalmol Vis Sci. 2017 Oct 1;58(12):5065-5075
C57BL/6NHsd mice Intracranial glioblastoma model Oral 50 mg/kg Daily administration for 14 days To evaluate the therapeutic effects and toxicity of PP1 in an intracranial glioblastoma model. Results showed that PP1 accumulated in tumor tissues and triggered extensive tumor cell death without significant toxicity. Transl Oncol. 2019 Jul;12(7):895-907.

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

3.14mL

0.63mL

0.31mL

15.69mL

3.14mL

1.57mL

31.37mL

6.27mL

3.14mL

Dissolving Methods
Please choose the appropriate dissolution scheme according to your animal administration guide.For the following dissolution schemes, clear stock solution should be prepared according to in vitro experiments, and then cosolvent should be added in turn:

in order to ensure the reliability of the experimental results, the clarified stock solution can be properly preserved according to the storage conditions; The working fluid for in vivo experiment is recommended to be prepared now and used on the same day;

The percentage shown in front of the following solvent refers to the volume ratio of the solvent in the final solution; If precipitation or precipitation occurs in the preparation process, it can be assisted by heating and/or ultrasound.
Protocol 1
Protocol 2

References

 

Historical Records

Categories